|
Baseline status
|
Patients in DAS28 remission, n (%)
|
Patients in modified ARA remission, n (%)
|
|---|
|
DAS28
|
BIOL (n = 775)
|
CON (n = 255)
|
BIOL (n = 764)
|
CON (n = 256)
|
|---|
|
>3.2 to 4.0
|
16 (45.7)
|
8 (33.3)
|
9 (26.5)
|
4 (16.0)
|
|
>4.0 to 5.1
|
33 (26.4)
|
16 (23.2)
|
18 (14.3)
|
10 (14.5)
|
|
>5.1 to 6.0
|
40 (22.1)
|
10 (13.5)
|
38 (20.9)
|
8 (10.8)
|
|
>6.0 to 7.0
|
28 (11.1)
|
4 (6.3)
|
25 (10.1)
|
3 (4.8)
|
|
> 7.0
|
9 (5.0)
|
1 (4.0)
|
11 (6.3)
|
1 (3.8)
|
|
Total
|
126 (16.3)
|
39 (15.3)
|
101 (13.2)
|
26 (10.2)
|
- ARA, American Rheumatology Association; BIOL, patients treated with biologics; CON, patients receiving conventional DMARD treatment (control group); DAS28, disease activity score based on 28 joint counts.
